type here...

CATEGORIES

Press Release

LATEST

1...101112Page 12 of 12

TRENDING

EDITORS CHOICE

ZEPOSIA® (ozanimod), a New Oral Treatment for Relapsing Forms of Multiple Sclerosis

Medika Life -
ZEPOSIA, a treatment for multiple sclerosis is the first and only approved sphingosine-1-phosphate (S1P) receptor modulator with no genetic test or first dose observation at initiation

Telemedicine Market Size Worth $298.9 Billion By 2028 | CAGR: 22.4%: Grand View Research, Inc.

Medika Life -
The global telemedicine market size is expected to reach USD 298.9 billion by 2028, according to a new report by Grand View Research

Treatment for Schizophrenia and Bipolar I Disorder Gets Vote of Support

Medika Life -
The Alkermes ALKS 3831 development program is part of our ongoing commitment to develop new therapeutic options for adults living with serious mental illness.

MMI SpA Launches Breakthrough Technology in Robotic Microsurgery

Medika Life -
The Symani Surgical System combines the benefits of tremor reduction and motion scaling (7-20x) with the world's smallest wristed instrumentation, offering seven degrees of freedom and dexterity

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories